ROR GAMMA T INHIBITORS AND TOPICAL USES THEREOF

The present disclosure is directed to use of RORγt inhibitors in the treatment of autoimmune disorders, e.g., autoimmune disorders of the skin. This disclosure is also directed to pharmaceutical compositions comprising an RORγt inhibitor and a pharmaceutically acceptable carrier for topical administ...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: HARDEN, Jamie, HOFLAND, Hans
Format: Patent
Sprache:eng ; fre
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The present disclosure is directed to use of RORγt inhibitors in the treatment of autoimmune disorders, e.g., autoimmune disorders of the skin. This disclosure is also directed to pharmaceutical compositions comprising an RORγt inhibitor and a pharmaceutically acceptable carrier for topical administration. La présente invention concerne l'utilisation d'inhibiteurs ee RORγt dans le traitement de troubles auto-immuns, par exemple, des troubles auto-immuns de la peau. La présente invention concerne également des compositions pharmaceutiques comprenant un inhibiteur de RORγt et un véhicule pharmaceutiquement acceptable pour une administration topique.